Additional Information

Alka Dwivedi received her PhD degree from Indian Institute of Technology Bombay, India in 2021 in developing indigenous CD19 CAR T cell therapy for leukemia and lymphoma patients. Then in 2021, she joined Taylor lab as a postdoctoral fellow. Currently, she is working on developing novel strategies with CAR T for the treatment of AML and ALL.